141 related articles for article (PubMed ID: 11392680)
1. [Evaluation of polymerase chain reaction method for monitoring of fungal infection in compromised hosts].
Ohta K; Yamane T; Hino M; Koh KR; Nakao T; Akahori M; Kanashima H; Sakamoto E; Hagihara K; Takubo T; Tatsumi N
Jpn J Antibiot; 2001 Mar; 54(3):103-11. PubMed ID: 11392680
[TBL] [Abstract][Full Text] [Related]
2. A novel comprehensive set of fungal Real time PCR assays (fuPCR) for the detection of fungi in immunocompromised haematological patients-A pilot study.
Rahn S; Schuck A; Kondakci M; Haas R; Neuhausen N; Pfeffer K; Henrich B
Int J Med Microbiol; 2016 Dec; 306(8):611-623. PubMed ID: 27765533
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
[TBL] [Abstract][Full Text] [Related]
4. [Quantitative PCR for diagnosis of invasive fungal infections in patients with hematologic malignancies].
Shao Q; Gao L; Wang LL; Ding Y; Yang H; Suo JJ; Shen DX; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):499-504. PubMed ID: 20416198
[TBL] [Abstract][Full Text] [Related]
5. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
[TBL] [Abstract][Full Text] [Related]
6. [Early and differential diagnosis for fungal infection by PCR in case of living donor liver transplantation].
Nakamura A; Kotera E; Moriguchi Y; Matsushima Y; Nishioka J; Morishita Y; Sakurai H; Yabu Y; Wada H; Uemoto S; Nobori T
Rinsho Byori; 2005 Aug; 53(8):685-91. PubMed ID: 16190352
[TBL] [Abstract][Full Text] [Related]
7. Similar efficacy of broad-range ITS PCR and conventional fungal culture for diagnosing fungal infections in non-immunocompromised patients.
Rampini SK; Zbinden A; Speck RF; Bloemberg GV
BMC Microbiol; 2016 Jun; 16(1):132. PubMed ID: 27349889
[TBL] [Abstract][Full Text] [Related]
8. Non-culture-based diagnostics for opportunistic fungi.
Mennink-Kersten MA; Verweij PE
Infect Dis Clin North Am; 2006 Sep; 20(3):711-27, viii. PubMed ID: 16984877
[TBL] [Abstract][Full Text] [Related]
9. New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients.
Chen SC; Kontoyiannis DP
Curr Opin Infect Dis; 2010 Dec; 23(6):567-77. PubMed ID: 20827189
[TBL] [Abstract][Full Text] [Related]
10. Opportunistic fungi: a view to the future.
Pappas PG
Am J Med Sci; 2010 Sep; 340(3):253-7. PubMed ID: 20823702
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
[TBL] [Abstract][Full Text] [Related]
12. Detection and investigation of invasive mould disease.
Cuenca-Estrella M; Bassetti M; Lass-Flörl C; Rácil Z; Richardson M; Rogers TR
J Antimicrob Chemother; 2011 Jan; 66 Suppl 1():i15-24. PubMed ID: 21177400
[TBL] [Abstract][Full Text] [Related]
13. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies.
Fukushima N; Mannen K; Okamoto S; Shinogi T; Nishimoto K; Sueoka E
Intern Med; 2005 Aug; 44(8):879-82. PubMed ID: 16157992
[TBL] [Abstract][Full Text] [Related]
14. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia.
von Lilienfeld-Toal M; Lehmann LE; Raadts AD; Hahn-Ast C; Orlopp KS; Marklein G; Purr I; Cook G; Hoeft A; Glasmacher A; Stüber F
J Clin Microbiol; 2009 Aug; 47(8):2405-10. PubMed ID: 19571034
[TBL] [Abstract][Full Text] [Related]
15. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
Zeng SY; Liu T; Meng WT; Chen YN
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
[TBL] [Abstract][Full Text] [Related]
16. Invasive infection due to Trichosporon cutaneum in patients with hematologic malignancies.
Kataoka-Nishimura S; Akiyama H; Saku K; Kashiwa M; Mori S; Tanikawa S; Sakamaki H; Onozawa Y
Cancer; 1998 Feb; 82(3):484-7. PubMed ID: 9452265
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative PCR for early diagnosis of invasive fungal infections in patients with hematologic malignancies].
Liu SJ; Wang X; Wang XH; Zhou H; Yuan D; Jiang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1225-30. PubMed ID: 23114153
[TBL] [Abstract][Full Text] [Related]
18. Improving efficacy of antifungal therapy by polymerase chain reaction-based strategy among febrile patients with neutropenia and cancer.
Lin MT; Lu HC; Chen WL
Clin Infect Dis; 2001 Nov; 33(10):1621-7. PubMed ID: 11595977
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of invasive fungal infections in immunocompromised children.
Dornbusch HJ; Groll A; Walsh TJ
Clin Microbiol Infect; 2010 Sep; 16(9):1328-34. PubMed ID: 20678175
[TBL] [Abstract][Full Text] [Related]
20. The impact of the host on fungal infections.
Perfect JR
Am J Med; 2012 Jan; 125(1 Suppl):S39-51. PubMed ID: 22196208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
